Scitech Life Sciences: Application for market approval of betamethasone active pharmaceutical ingredients has been approved.

On March 16th, Saito Bio announced that its holding subsidiary, Shandong Suirui Pharmaceutical Co., Ltd., recently received the "Chemical Raw Material Drug Market Application Approval Notice" for betamethasone issued by the National Medical Products Administration. Betamethasone is a type of steroid drug mainly used to treat allergies and autoimmune inflammatory conditions. It can help the body reduce inflammation, prevent tissue damage from excessive inflammation, and also suppress immune system overreactions and allergy symptoms.